Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Therma Bright Prepares FDA 513(g) Review Document for its AI-Driven Digital Cough Analyzer (DCA)
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers AAPL TBRIF TSX-V:THRM
Eyes On Novartis, Gilead, Bristol Myers As FDA Weighs Risks Vs. Benefits Of Approved CAR T-Cell Therapies
Via Benzinga
Exposures Product Safety
Tickers BMY GILD JNJ NVS
Distinguished author and life coach Eric North shares guidance on making the holidays happier
Via IssueWire
Topics Product Recall
Exposures Legal Product Safety
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
Tickers SCYX
New Partnership Between Generis And Risetime Provides Easy and Compliant Information Management for Cosmetics Industry
Via PRLog
Exposures Product Safety
Tickers PFE
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Via TheNewswire.com
Exposures Product Safety
Tickers ASX:IMU IUGNF
Imugene thrilled as VAXINIA granted FDA Fast Track designation
Via News Direct
Exposures Product Safety
Tickers ASX:IMU IUGNF
Li & Liao Optometry Acquires IPL: the Only FDA-Approved Device for Dry Eye
Via Press Advantage
Exposures Product Safety
SpringWorks Catapults 24% On A 'Watershed Moment' In Cancer Treatment
Via Investor's Business Daily
Exposures Product Safety
Tickers SWTX
FDA Rejects Aldeyra Therapeutics' Dry Eye Disease Candidate, Asks For Additional Study
Via Benzinga
Exposures Product Safety
Tickers ALDX
Unlocking Potential: Immunoassay Market Insights on Industry Size, Key Trends, Emerging Demands, and Prospects Extending to (2023-2028)
Via SBWire
Exposures Product Safety
Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Exposures Product Safety
Tickers ALYA ARGX ASST CWBR
FDA Approves SpringWorks Therapeutics' Lead Therapy As First For Subtype Of Soft Tissue Sarcomas
Via Benzinga
Exposures Product Safety
Tickers SWTX
ROSEN, A RESPECTED AND LEADING FIRM, Encourages Outlook Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers OTLK
PsychedelicNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Featured in Goldman Small Cap Research Report, Receives Approval for Celly Nu Plan of Arrangement
Via Investor Brand Network
Exposures Product Safety
Tickers CSE:HUGE HUGE
5 Investors Betting Big on RedHill Biopharma (RDHL) Stock
Via InvestorPlace
Exposures Product Safety
Tickers RDHL
Digital Marketing Agency Owner Stephanie Solheim Featured in Ani Hoang’s Podcast, The Aspiring CMO
Via Press Advantage
Topics Product Recall
Exposures Legal Product Safety
Mark Ridley’s New Children’s Book: The Fly & The Truck Driver
Via AB Newswire
Topics Bonds Product Recall
Exposures Debt Markets Legal Product Safety
Why Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today?
Via Benzinga
Exposures Product Safety
Tickers RDHL
The 250th Anniversary of the Boston Tea Party: Reflecting on the American Revolution and Independence
Via Get News
Topics Product Recall
Exposures Legal Product Safety
Gene Therapy Market Research: Exploring Market Size, Business Growth, Career Prospects, Industry Trends, and Projections for 2028
Via SBWire
Exposures Product Safety
Tickers NVS
ROSEN, A TOP RANKED LAW FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
Tickers SCYX
ROSEN, LEADING TRIAL ATTORNEYS, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
Tickers SCYX
NATIONALLY RANKED ROSEN LAW FIRM Encourages Outlook Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - OTLK
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers OTLK
Embark on a Culinary Journey with KINIKORA’s Authentic Korean Yakgwa – The Perfect Blend of Tradition and Taste
Via AB Newswire
Exposures Product Safety
ROSEN, NATIONAL INVESTOR COUNSEL, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SCYX
Via NewMediaWire
Topics Lawsuit Product Recall
Exposures Financial Legal Product Safety
Tickers SCYX
From Code to Compassion: How Roger Kurian’s Tech Expertise Fuels His Philanthropy
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Tickers JPM WFC
Transforming Eye Care: RAIN Offers Preservative-Free, Sterile-Sealed Eye Drops for Improved Eye Health
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Pharmacy Stars Champions Drug Safety with Live Book Discussion Featuring Industry Expert
Via AB Newswire
Topics Economy
Exposures Product Safety Supply Chain
Genprex Inc. (NASDAQ: GNPX) Granted Orphan Drug Designation in Small Cell Lung Cancer by FDA, Presented Data at Two October Events Focused on Lung Cancer
Via Investor Brand Network
Exposures Product Safety
Tickers GNPX
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.